Is Clorox Co (CLX) About to Shake Its Skeptics?

Despite its fantastic technical performance, Clorox Co (NYSE:CLX) is surrounded by pessimism on Wall Street

May 3, 2016 at 2:55 PM
facebook X logo linkedin


Consumer goods stock Clorox Co (NYSE:CLX) is booming today, despite the broad-market sell-off. The stock has added 3% to trade at $130.79, after the company handily topped expectations with its fiscal third-quarter earnings results -- while announcing the purchase of digestion specialist Renew Life. This shouldn't come as a surprise, though, considering CLX has moved higher following six of its last eight earnings reports. Moreover, the stock has steadily climbed higher in recent years, adding 50% in the past 24 months, and earlier today touched a record high of $132.50. 

With a technical showing like this, one would assume CLX has plenty of optimistic followers on Wall Street. However, the data shows a much different story. In fact, just one brokerage firm recommends buying the stock, while seven deem it a "hold," and four call it a "sell" or worse. Plus, CLX's average 12-month price target among analysts actually sits at a discount to current levels, coming in at $121.42. 

Analysts aren't alone in their seemingly unwarranted pessimism. Clorox sports elevated short-interest levels, as it would take short sellers more than six sessions to cover their positions, at the stock's average daily volumes. Not only that, but short interest actually jumped 12.6% in the latest reporting period, so it's not like these bears have been in a hurry to buy back their shorted shares. 

Options traders have also exhibited bearish traits. During the past 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), for example, put buying has outpaced call buying by a slim margin. Even today, after the company's impressive earnings report and all-time high, CLX puts are trading at 12 times the average intraday pace, and more than triple calls.

Taking another look at the charts, CLX gapped above its 100-day moving average today, which marked the stock's intraday high on Monday. The 200-day trendline is also worth mentioning, as it has neatly contained a handful of CLX pullbacks in the past year. 

Based on all this, Clorox Co (NYSE:CLX) appears to be a prime target for contrarian traders. The stock has consistently outperformed on a technical and fundamental basis, yet it is surrounded by doubt. If CLX can continue pushing higher, analysts and traders may come to their senses, and that shift in sentiment could act as yet another tailwind for the stock. 
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI